$465 Million Settlement in Our Client’s Qui Tam Whistleblower Case Over Pharmaceutical Manufacturer’s Underpaying Medicaid Rebates for New EpiPen Products


Through a $465 million settlement, Finch McCranie’s Michael A. Sullivan and James J. Breen of the Breen Law Firm successfully represented a whistleblower whose qui tam case under the False Claims Act helped return hundreds of millions to the United States and various states for Medicaid rebates underpaid on new EpiPen products introduced in 2009.

The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. Mylan Inc., et al., and our case, United States, et al. ex rel. Ven-A-Care of the Florida Keys, Inc. Mylan Inc., et al..

These cases illustrate the importance of the False Claims Act to uncover and stop fraud and false claims in health care and other industries, which harm taxpayers by stealing taxpayer dollars needed to provide medical care and other services.

About Finch McCranie 

Finch McCranie, LLP is one of the most experienced specialty law firms in the United States, with a history of more than 50 years. Led by former federal prosecutors, its practice includes compliance, monitorships and internal investigations; white collar criminal defense; representation of whistleblowers worldwide in qui tam litigation under the False Claims Act, and in the IRS and SEC Whistleblower Programs; complex business litigation and serious injury litigation. The firm is headquartered in Atlanta, Ga. with two attorneys, both former Department of Justice trial attorneys, based in Washington, D.C. Finch McCranie has earned the highest rating from Martindale-Hubbell, which rates law firms nationwide. http://www.qui-tam-litigation.com, http://www.finchmccranie.com/